RxDoctor Payments Data

Kathy Willenborg

Psychiatric/Mental Health · Anna, ILNPI 1760770085

Payments from drug & device makers

$1,564in general payments, 2019–2025

Across 89 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$337
  • E.r. Squibb & Sons, L.L.C.$263
  • AbbVie$260
  • Johnson & Johnson$212
  • Otsuka America Pharmaceutical, Inc.$169
  • Neurocrine Biosciences, Inc.$103
  • plus $221 from 5 others

What the payments were for

  • Food & beverage$1,564100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,564 in reported general payments places this provider in the 75th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$13,263
Medicare patients
50
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate12$35,244
VraylarCariprazine Hcl17$25,527
Lurasidone Hcl11$1,221
Oxcarbazepine21$910
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$724
Quetiapine Fumarate43$649
Buspirone Hcl50$633
Prazosin Hcl27$425
Benztropine Mesylate27$370
Hydroxyzine Hcl19$340
Aripiprazole17$334
Bupropion XlBupropion Hcl19$328
Olanzapine20$284
Doxepin Hcl13$260
Hydroxyzine Pamoate18$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$212$35,24412 claims
AbbVieVraylar$260$25,52717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Anna

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →